Company · CIK 0001205922 · SIC 2834 — Pharmaceutical Preparations · OTC
VACCINEX, INC. · VCNX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2019 PForm 4 → | Feb 8, 4:34 pm EST | Scott E. RoyerChief Financial Officer | 2,000 | $4.98 | $9,968 | 3,999 | +100% | plan? |
| Jan 15, 2019 PForm 4 → | Jan 17, 4:29 pm EST | Scott E. RoyerChief Financial Officer | 1,688 | $4.31 | $7,275 | 1,999 | +543% | plan? |
| Dec 27, 2018 PForm 4 → | Dec 31, 4:10 pm EST | Scott E. RoyerChief Financial Officer | 311 | $4.15 | $1,291 | 311 | — | plan? |
| Aug 13, 2018 PForm 4 → | Aug 15, 4:50 pm EDT | Albert Friedberg +1Director, 10% Owner | 2,458,333 | $12.00 | $29,499,996 | 583,333 | — | plan? |
| Aug 13, 2018 CForm 4 → | Aug 15, 4:50 pm EDT | Albert Friedberg +1Director, 10% Owner | 2,946,363 | — | — | 2,913,469 | — | plan? |
| Aug 13, 2018 CForm 4 → | Aug 15, 4:49 pm EDT | Antibody Investments LLC +110% Owner | 1,895,583 | — | — | 1,895,583 | — | plan? |
| Aug 13, 2018 CForm 4 → | Aug 15, 4:49 pm EDT | Maurice Zauderer +1President and CEO, Director, 10% Owner | 1,100,141 | — | — | 815,698 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2018 JForm 4 → | Aug 15, 4:50 pm EDT | Jacob B. FriebergDirector | 75,000 | — | — | 75,000 | — | |
| Aug 13, 2018 CJForm 4 → | Aug 15, 4:50 pm EDT | Albert Friedberg +1Director, 10% Owner | 47,664,296 | — | — | 21,475,000 | — | |
| Aug 13, 2018 CForm 4 → | Aug 15, 4:49 pm EDT | Antibody Investments LLC +110% Owner | 12,700,387 | — | — | 0 | — | |
| Aug 13, 2018 CForm 4 → | Aug 15, 4:49 pm EDT | Maurice Zauderer +1President and CEO, Director, 10% Owner | 9,890,214 | — | — | 0 | — |